Compass GIST
21 Dec 2020
BLU-285-1304
–
An International, Multicenter, Open-label, Randomized, Phase 3 Study of Avapritinib vs Sunitinib in Patients with Genomically Selected Gastrointestinal Stromal Tumor (GIST)
–
Cancer Type | Bowel and Colon, Stomach & Oesophageal |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | - |
Cancer Stage | All stages |
Anticipated Start Date | - |
Anticipated End Date | - |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | Dr Amitesh Roy |
Recruitment Status | Not Yet Recruiting |